Pharmacognosy Reviews logo
Submit
Pharmacognosy ReviewsACADEMIC PUBLISHING
Review

Plant-derived Anti-arthritic Nanomedicines for Effective Therapy in the Management of Inflammatory Diseases

1, 1, 1

  1. 1Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, INDIA.

CORRESPONDENCE

Malay Kumar Das

Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam, INDIA.

mkdps@dibru.ac.in

Received: 07-10-2022; Accepted: 03-11-2022.

Volume 17, Issue 33 · pp. 104-122 · 2023 · DOI: 10.5530/097627870287

ABSTRACT

Arthritis comes under the bandwagon of one of the most menacing diseases that are known to mankind and the more concerning matter is unavailability of permanent cure for this condition. The conditions of severe joint inflammation are being treated with conventional therapeutics that imparts a range of adverse effects, which prompted the researchers to look for safer options in the form of herbal medicines. Numerous plants, their parts, extracts, and their phyto-isolates have been explored till date for their anti-arthritic potential. However, there are risks of stability and delivery issues with these plant products, hence limiting their utility for effective therapy in the management of inflammatory diseases. Nanotechnology based herbal medicines may overcome the delivery limitation of various natural products utilizing the multi and versatile properties of various nanoparticles. This review reports the herbal anti-arthritic drugs, challenges associated with them, and pharmacodynamics/ pharmacokinetics of anti-arthritic herbal nanomedicines.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Singha, L. R., Das, S. D., & Das, M. K. (2023). Plant-derived Anti-arthritic Nanomedicines for Effective Therapy in the Management of Inflammatory Diseases. Pharmacognosy Reviews, 17(33), 104-122. https://doi.org/10.5530/097627870287

    Copyright and licence

    © 2023 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which allows others to share and adapt the work for any purpose, as long as the original authors and source are credited. CC BY 4.0